ArticleScientific reports2025
Incremental prognostic value of ischemic score quantified by stress dynamic CT myocardial perfusion in patients with and without diabetes mellitus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic impact of epicardial fat volume, anatomical and functional imaging across the cardiovascular risk spectrum in patients with suspected coronary artery disease: a single-center retrospective cohort study.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess the incremental prognostic value of ischemic score quantified by stress dynamic CT myocardial perfusion imaging (CT-MPI) in patients with and without diabetes mellitus (DM). 331 patients (92 patients with DM) with suspected coronary artery disease (CAD) who underwent coronary computed tomography angiography (CCTA) and CT-MPI were included. Major adverse cardiovascular events (MACE) included cardiac death, acute coronary syndrome (ACS), late revascularization, and hospitalizations attributable to heart failure. Ischemic score was assessed based on reduced myocardial blood flow across 16 segments. An ischemic perfusion defect (IPD) was identified as ischemic score ≥ 4. During a median follow-up of 15 (9, 40) months, 49 patients (14.8%) experienced MACE. IPD was an independent predictor for the development of MACE in both DM (HR: 11.64, p = 0.019) and non-DM patient groups (HR: 8.66, p = 0.004). Adding IPD to clinical risk factors and CCTA characteristics increased the C-index for predicting MACE from 0.72 to 0.80 in DM patients (p = 0.005) and from 0.76 to 0.83 in non-DM patients (p = 0.006). IPD quantified by stress dynamic CT-MPI had incremental prognostic value over traditional clinical risk factors and anatomic parameters in both DM and non-DM patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.